NBIX
NASDAQStockNeurocrine Biosciences, Inc.
$129.78+1.65 (+1.29%)
52-Week Range
$87.54
$155.63
Key Stats
Market Cap
13.0B
P/E Ratio
27.78
Dividend Yield
—
Beta
0.36
Volume
646.5K
Avg Volume
1.1M
Performance
1M
+2.95%
3M
-17.06%
6M
-9.31%
YTD
-9.12%
1Y
+14.60%
3Y
+35.58%
5Y
+35.10%
Price Chart
ETF Exposure
NBIX is held by 380 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| AVLC | Avantis U.S. Large Cap Equity ETF | 0.03% |
| IALT | iShares Systematic Alternatives Active ETF | 0.03% |
| QARP | Xtrackers Russell 1000 US Quality at a Reasonable Price ETF | 0.03% |
| CVLC | Calvert US Large-Cap Core Responsible Index ETF | 0.03% |
| ENHU | iShares Enhanced Large Cap Core Active ETF | 0.03% |
| ESGV | Vanguard ESG U.S. Stock ETF | 0.03% |
| GEQT.TO | iShares ESG Equity ETF Portfolio | 0.03% |
| TILT | FlexShares Morningstar U.S. Market Factor Tilt Index Fund | 0.03% |
| XRME.F | Xtrackers MSCI USA ESG Screened UCITS ETF | 0.02% |
| XRSS.L | Xtrackers MSCI USA Screened UCITS ETF 1C | 0.02% |
| XWD1.F | Xtrackers MSCI World Swap UCITS ETF | 0.02% |
| XWD1.SG | Xtrackers MSCI World Swap UCITS ETF | 0.02% |
| XWEH.DE | Xtrackers MSCI World Swap UCITS ETF 4C EUR Hedged | 0.02% |
| IGDA.L | Invesco Dow Jones Islamic Global Developed Markets UCITS ETF | 0.02% |
| CU1.L | iShares MSCI USA UCITS ETF | 0.02% |
| DFAU | Dimensional - US Core Equity Market ETF | 0.02% |
| ISMCF | iShares MSCI USA UCITS ETF | 0.02% |
| MFUS | PIMCO RAFI Dynamic Multi-Factor U.S. Equity ETF | 0.02% |
| USCHWH.SW | UBS Core MSCI USA hCHF UCITS ETF CHF acc | 0.02% |
| CSY1.DE | UBS MSCI USA NSL UCITS ETF USD acc | 0.02% |
| GPSA.L | iShares MSCI USA Screened UCITS ETF | 0.02% |
| PBUS | Invesco MSCI USA ETF | 0.02% |
| SLUS.DE | iShares MSCI USA Screened UCITS ETF | 0.02% |
| TACU | T. Rowe Price Active Core U.S. Equity ETF | 0.02% |
| UC03.L | UBS Core MSCI USA UCITS ETF USD dis | 0.02% |
| UC04.L | UBS Core MSCI USA UCITS ETF USD dis | 0.02% |
| XD9D.DE | Xtrackers MSCI USA UCITS ETF 1D | 0.02% |
| XD9U.DE | Xtrackers MSCI USA UCITS ETF 1C | 0.02% |
| XD9U.L | Xtrackers MSCI USA UCITS ETF 1C | 0.02% |
| XDUS.L | Xtrackers MSCI USA UCITS ETF 1C | 0.02% |
| MXUD.L | Invesco MSCI USA UCITS ETF | 0.02% |
| SC0H.DE | Invesco MSCI USA UCITS ETF | 0.02% |
| GGRO.TO | iShares ESG Growth ETF Portfolio | 0.02% |
| SCHK | Schwab 1000 Index ETF | 0.02% |
| SCHX | Schwab U.S. Large-Cap ETF | 0.02% |
| UB0A.L | UBS Core MSCI USA UCITS ETF hGBP acc | 0.02% |
| VONE | Vanguard Russell 1000 ETF | 0.02% |
| DFUS | Dimensional - US Equity Market ETF | 0.02% |
| GUSA | Goldman Sachs MarketBeta US 1000 Equity ETF | 0.02% |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | 0.02% |
| IWB | iShares Russell 1000 ETF | 0.02% |
| IYY | iShares Dow Jones U.S. ETF | 0.02% |
| RECS | Columbia Research Enhanced Core ETF | 0.02% |
| SCHB | Schwab U.S. Broad Market ETF | 0.02% |
| SDWD.L | iShares MSCI World Screened UCITS ETF | 0.02% |
| SPPW.DE | State Street SPDR MSCI World UCITS ETF | 0.02% |
| SPTM | State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF | 0.02% |
| SWLD.L | State Street SPDR MSCI World UCITS ETF | 0.02% |
| VTHR | Vanguard Russell 3000 ETF | 0.02% |
| VTI | Vanguard Total Stock Market ETF | 0.02% |
About NBIX ETF Exposure
Neurocrine Biosciences, Inc. (NBIX) is held by 380 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 13.0B, NBIX is a widely held institutional stock. The stock currently trades at $129.78. Investors can gain exposure to NBIX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold NBIX, sorted by portfolio weight.